scholarly article | Q13442814 |
P2093 | author name string | Harold D. Schultz | |
Kaushik P. Patel | |||
P2860 | cites work | A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 | Q24290169 |
Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression | Q24295246 | ||
Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism | Q24300310 | ||
Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation | Q24311938 | ||
Beneficial versus harmful effects of Angiotensin (1-7) on impulse propagation and cardiac arrhythmias in the failing heart | Q24337673 | ||
The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function | Q24633556 | ||
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas | Q24680069 | ||
Central neural control of sympathetic nerve activity in heart failure following exercise training | Q27691407 | ||
Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function | Q28264715 | ||
Angiotensin-(1-7) and the renin-angiotensin system | Q28287695 | ||
A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link? | Q33625889 | ||
Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension | Q33639490 | ||
Elevated mitochondrial superoxide contributes to enhanced chemoreflex in heart failure rabbits | Q33686588 | ||
Role of nitric oxide in the neural control of cardiovascular function | Q33847630 | ||
Expression of neuronal nitric oxide synthase in rabbit carotid body glomus cells regulates large-conductance Ca2+-activated potassium currents | Q33923537 | ||
ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function | Q33983361 | ||
Angiotensin-(1-12) requires angiotensin converting enzyme and AT1 receptors for cardiovascular actions within the solitary tract nucleus | Q34150500 | ||
The brain renin-angiotensin system: location and physiological roles. | Q34188368 | ||
Nuclear angiotensin-(1–7) receptor is functionally coupled to the formation of nitric oxide | Q34305539 | ||
Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy. | Q34480216 | ||
Angiotensin-(1-7) increases neuronal potassium current via a nitric oxide-dependent mechanism | Q34501670 | ||
ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. | Q34784864 | ||
Angiotensin II and angiotensin-1-7 redox signaling in the central nervous system | Q34785701 | ||
Thiol-based redox switches and gene regulation | Q35040525 | ||
Angiotensin peptides and central autonomic regulation | Q35059998 | ||
The role of ACE2 in cardiovascular physiology | Q35105871 | ||
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney | Q35215135 | ||
Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure: role for CAPON and Ang II | Q35353243 | ||
Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system | Q35567432 | ||
NADPH oxidase-derived superoxide anion mediates angiotensin II-enhanced carotid body chemoreceptor sensitivity in heart failure rabbits | Q36114032 | ||
Membrane-associated zinc peptidase families: comparing ACE and ACE2. | Q36212498 | ||
Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway. | Q36579769 | ||
Exercise training improves peripheral chemoreflex function in heart failure rabbits | Q36877438 | ||
Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure? | Q36929193 | ||
Angiotensin-converting enzyme 2 overexpression improves central nitric oxide-mediated sympathetic outflow in chronic heart failure | Q37079211 | ||
Role of CuZn superoxide dismutase on carotid body function in heart failure rabbits | Q37096990 | ||
Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology | Q37127739 | ||
New angiotensins | Q37147841 | ||
Angiotensin-converting enzyme 2 in the brain: properties and future directions | Q37155907 | ||
Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice | Q37225431 | ||
Injections of angiotensin-converting enzyme 2 inhibitor MLN4760 into nucleus tractus solitarii reduce baroreceptor reflex sensitivity for heart rate control in rats | Q37247541 | ||
Renin-angiotensin system revisited | Q37269647 | ||
Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease | Q37349063 | ||
AT1a receptor knockout in mice impairs urine concentration by reducing basal vasopressin levels and its receptor signaling proteins in the inner medulla | Q37383377 | ||
Angiotensin and carotid body chemoreception in heart failure | Q37829530 | ||
Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7/MAS-1-dependent pathways. | Q39692023 | ||
Angiotensin-(1-7) activates growth-stimulatory pathways in human mesangial cells | Q39909569 | ||
Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells | Q40373012 | ||
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. | Q40510688 | ||
ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts. | Q42514935 | ||
Baroreflex improvement in shr after ace inhibition involves angiotensin-(1-7). | Q43612370 | ||
Renal segmental microvascular responses to ANG II in AT1A receptor null mice | Q44214900 | ||
Angiotensin-(1-7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors | Q44611338 | ||
Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors | Q44790566 | ||
Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney. | Q45027966 | ||
Angiotensin-(1-7) inhibitory mechanism of norepinephrine release in hypertensive rats | Q45069630 | ||
Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase | Q45086400 | ||
Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats | Q45101312 | ||
Myocardial infarction increases ACE2 expression in rat and humans. | Q45238600 | ||
Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension | Q45349900 | ||
Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics | Q46160779 | ||
Renal ACE2 expression and activity is unaltered during established hypertension in adult SHRSP and TGR(mREN2)27. | Q46483030 | ||
Chronic angiotensin (1-7) injection accelerates STZ-induced diabetic renal injury | Q46531046 | ||
Gene transfer of neuronal nitric oxide synthase to carotid body reverses enhanced chemoreceptor function in heart failure rabbits | Q46580788 | ||
Angiotensin-(1-7) immunoreactivity in the hypothalamus of the (mRen-2d)27 transgenic rat. | Q47836966 | ||
Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain. | Q48171114 | ||
Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats | Q48260358 | ||
Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors | Q48306718 | ||
Angiotensin II in central nervous system physiology | Q48311566 | ||
Altered number of diaphorase (NOS) positive neurons in the hypothalamus of rats with heart failure | Q48445281 | ||
Decreased gene expression of neuronal nitric oxide synthase in hypothalamus and brainstem of rats in heart failure | Q48914448 | ||
Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus. | Q50511397 | ||
Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. | Q51802034 | ||
Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system. | Q53593286 | ||
Angiotensin-(1-7) prevents atrial fibrosis and atrial fibrillation in long-term atrial tachycardia dogs. | Q54446381 | ||
Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3',5'-cyclic monophosphate-dependent pathway. | Q54705117 | ||
ACE2–angiotensin-(1–7)–Mas axis in renal ischaemia/reperfusion injury in rats | Q56774944 | ||
Interaction of bradykinin and angiotensin-(1–7) in the central modulation of the baroreflex control of the heart rate | Q62124895 | ||
RNA interference shows interactions between mouse brainstem angiotensin AT1 receptors and angiotensin-converting enzyme 2 | Q64376766 | ||
The role of endogenous angiotensin II in the regulation of renal haemodynamics and proximal fluid reabsorption in the rat | Q67965232 | ||
NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats | Q73371618 | ||
Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7) | Q79349822 | ||
Enhanced sensitivity of Kv channels to hypoxia in the rabbit carotid body in heart failure: role of angiotensin II | Q79733827 | ||
Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II | Q80077979 | ||
Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats | Q80590177 | ||
Effects of intracerebroventricular infusion of angiotensin-(1-7) on bradykinin formation and the kinin receptor expression after focal cerebral ischemia-reperfusion in rats | Q81419036 | ||
ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction | Q84314698 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cardiovascular disease | Q389735 |
P304 | page(s) | 1121-32 | |
P577 | publication date | 2013-10-01 | |
P1433 | published in | Antioxidants & Redox Signaling | Q4775078 |
P1476 | title | Angiotensin peptides and nitric oxide in cardiovascular disease | |
P478 | volume | 19 |
Q51186140 | Cellular basis of angiotensin-(1-7)-induced augmentation of left ventricular functional performance in heart failure. |
Q35437365 | Modulation of angiotensin II signaling following exercise training in heart failure |
Q38790904 | Post-translational regulation of neuronal nitric oxide synthase: implications for sympathoexcitatory states |
Q36785528 | ROS and endothelial nitric oxide synthase (eNOS)-dependent trafficking of angiotensin II type 2 receptor begets neuronal NOS in cardiac myocytes. |
Q96018023 | Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost |
Q47851502 | The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7). |
Q41884591 | The Proatherogenic Effect of Chronic Nitric Oxide Synthesis Inhibition in ApoE-Null Mice Is Dependent on the Presence of PPAR α. |
Q38253635 | The role of local renin-angiotensin system in arterial chemoreceptors in sleep-breathing disorders |
Search more.